Disease areas of focus
Our Progress by Disease Area
- We currently are working on 16 disease areas that have all been patented, archived in an international depositary and successfully completed pilot studies & toxicology tests.
- Several of our disease areas have progressed further and have initiated or completed their pre-clinical trial phase.
- All disease areas projects are structured as a separate subsidiary of the parent company Cell & Gene Therapy ltd, allowing each project to separate its intellectual property.
- This makes it possible for investors to invest into a specific disease area project if they wish to, rather than the entire parent company
Partnerships & Alliances:
- We are currently looking to build alliances & partnerships with potential investors to progress our disease area projects accross our portfolio
- If you are interested in this opportunity then you can contact us here.